BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 8163504)

  • 1. G(i) alpha 2- and G(o) alpha-mediated signaling in the Pit-1-dependent inhibition of the prolactin gene promoter. Control of transcription by dopamine D2 receptors.
    Lew AM; Yao H; Elsholtz HP
    J Biol Chem; 1994 Apr; 269(16):12007-13. PubMed ID: 8163504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitory control of prolactin and Pit-1 gene promoters by dopamine. Dual signaling pathways required for D2 receptor-regulated expression of the prolactin gene.
    Elsholtz HP; Lew AM; Albert PR; Sundmark VC
    J Biol Chem; 1991 Dec; 266(34):22919-25. PubMed ID: 1835974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A dopamine-responsive domain in the N-terminal sequence of Pit-1. Transcriptional inhibition in endocrine cell types.
    Lew AM; Elsholtz HP
    J Biol Chem; 1995 Mar; 270(13):7156-60. PubMed ID: 7706253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective inhibition of prolactin gene transcription by the ETS-2 repressor factor.
    Day RN; Liu J; Sundmark V; Kawecki M; Berry D; Elsholtz HP
    J Biol Chem; 1998 Nov; 273(48):31909-15. PubMed ID: 9822660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of Go-coupled dopamine D2 receptors inhibits ERK1/ERK2 in pituitary cells. A key step in the transcriptional suppression of the prolactin gene.
    Liu JC; Baker RE; Sun C; Sundmark VC; Elsholtz HP
    J Biol Chem; 2002 Sep; 277(39):35819-25. PubMed ID: 12121979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetic mechanisms in the dopamine D2 receptor-dependent inhibition of the prolactin gene.
    Liu JC; Baker RE; Chow W; Sun CK; Elsholtz HP
    Mol Endocrinol; 2005 Jul; 19(7):1904-17. PubMed ID: 15731170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of chinook salmon growth hormone promoter activity by the adenosine 3',5'-monophosphate (cAMP)-dependent pathway involves two cAMP-response elements with the CGTCA motif and the pituitary-specific transcription factor Pit-1.
    Wong AO; Le Drean Y; Liu D; Hu ZZ; Du SJ; Hew CL
    Endocrinology; 1996 May; 137(5):1775-84. PubMed ID: 8612514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The D2 receptor: blocked transcription in GH3 cells and cellular pathways employed by D2A to regulate prolactin promoter activity.
    Fischberg DJ; Bancroft C
    Mol Cell Endocrinol; 1995 Jun; 111(2):129-37. PubMed ID: 7556874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coupling of a cloned rat dopamine-D2 receptor to inhibition of adenylyl cyclase and prolactin secretion.
    Albert PR; Neve KA; Bunzow JR; Civelli O
    J Biol Chem; 1990 Feb; 265(4):2098-104. PubMed ID: 1688845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mediation by calcium of thyrotropin--releasing hormone action on the prolactin promoter via transcription factor pit-1.
    Yan GZ; Bancroft C
    Mol Endocrinol; 1991 Oct; 5(10):1488-97. PubMed ID: 1775132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcriptional induction of the human prolactin gene by cAMP requires two cis-acting elements and at least the pituitary-specific factor Pit-1.
    Peers B; Monget P; Nalda MA; Voz ML; Berwaer M; Belayew A; Martial JA
    J Biol Chem; 1991 Sep; 266(27):18127-34. PubMed ID: 1655738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of D2 dopamine receptors inhibits estrogen response element-mediated estrogen receptor transactivation in rat pituitary lactotrophs.
    Ishida M; Mitsui T; Izawa M; Arita J
    Mol Cell Endocrinol; 2013 Aug; 375(1-2):58-67. PubMed ID: 23701824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonpituitary human prolactin gene transcription is independent of Pit-1 and differentially controlled in lymphocytes and in endometrial stroma.
    Gellersen B; Kempf R; Telgmann R; DiMattia GE
    Mol Endocrinol; 1994 Mar; 8(3):356-73. PubMed ID: 8015553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. G protein preferences for dopamine D2 inhibition of prolactin secretion and DNA synthesis in GH4 pituitary cells.
    Albert PR
    Mol Endocrinol; 2002 Aug; 16(8):1903-11. PubMed ID: 12145343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular cloning of the chicken prolactin gene and activation by Pit-1 and cAMP-induced factor in GH3 cells.
    Ohkubo T; Tanaka M; Nakashima K
    Gen Comp Endocrinol; 2000 Aug; 119(2):208-16. PubMed ID: 10936041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. G protein specificity in receptor-effector coupling. Analysis of the roles of G0 and Gi2 in GH4C1 pituitary cells.
    Liu YF; Jakobs KH; Rasenick MM; Albert PR
    J Biol Chem; 1994 May; 269(19):13880-6. PubMed ID: 8188665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dopamine D2 receptor mediates both inhibitory and stimulatory actions on prolactin release.
    Chang A; Shin SH; Pang SC
    Endocrine; 1997 Oct; 7(2):177-82. PubMed ID: 9549043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pit-1 binding sequences permit calcium regulation of human prolactin gene expression.
    Hoggard N; Davis JR; Berwaer M; Monget P; Peers B; Belayew A; Martial JA
    Mol Endocrinol; 1991 Nov; 5(11):1748-54. PubMed ID: 1779976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reconstitution of the protein kinase A response of the rat prolactin promoter: differential effects of distinct Pit-1 isoforms and functional interaction with Oct-1.
    Diamond SE; Chiono M; Gutierrez-Hartmann A
    Mol Endocrinol; 1999 Feb; 13(2):228-38. PubMed ID: 9973253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Constitutively active Gq-alpha stimulates prolactin promoter activity via a pathway involving Raf activity.
    Tian J; Ma HW; Bancroft C
    Mol Cell Endocrinol; 1995 Aug; 112(2):249-56. PubMed ID: 7489829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.